Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 28, 1998 - Issue 7
Submit an article Journal homepage
91
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Metabolism of 2-ethylhexanoic acid administered orally or dermally to the female Fischer 344 rat1

J. C. ENGLISH Health and Environment Laboratories, Eastman Kodak Company, Kodak Park, Building 320, Rochester, NY, 14652-6272, USA
,
P. J. DEISINGER Health and Environment Laboratories, Eastman Kodak Company, Kodak Park, Building 320, Rochester, NY, 14652-6272, USA
&
D. GUEST Health and Environment Laboratories, Eastman Kodak Company, Kodak Park, Building 320, Rochester, NY, 14652-6272, USA
Pages 699-714 | Published online: 22 Sep 2008

References

  • ALBRO, P. W., 1975, The metabolism of 2-EH in rats. Xenobiotica, 5,625–636.
  • Bui, L. M., TAUBENECK, M. W., FABER, W. and KEEN, C. L., 1997, Altered zinc (Zn) metabolism contributes to the developmental toxicity of 2-ethylhexanoic acid (EHXA) in Sprague-Dawley rats. Teratology, 55(1), 60, Abstract P15.
  • DEBINGER, P. J., BOATMAN, R. J. and GUEST, D., 1994, Metabolism of 2-ethylhexanol administered orally and dermally to the female Fischer 344 rat. Xenobiotica, 24, 429–440.
  • DICARLO, F. J., 1990, Structure—activity relationships (SAR) and structure—metabolism relationships (SMR) affecting the teratogenicity of carboxylic acids. Drug Metabolism Reviews, 22, 411–449.
  • FARRIER, D. S., 1997, PK Solutions User Guide, Version 2.0. (Ashland, OH, USA: Summit Research Services).
  • HENDRICKX, A. G., PETERSON, P. E., TYL, R. W., FISHER, L. C., FOSNIGHT, L. J., KUBENA, M. F., VRBANIC, M. A. and KATZ, G. V., 1993, Assessment of the developmental toxicity of 2-ethylhexanoic acid in rat and rabbits. Fundamental and Applied Toxicology, 20, 199–209.
  • JUBERG, DR., DAVID, R. M., KATZ, G. V., BERNARD, L. G., GORDON, DR., VLAOVIC, MS. and TOPPING, D. C., 1998, 2-Ethylhexanoic acid: subchronic oral toxicity studies in the rat and mouse, Food and Chemical Toxicology (in press).
  • KATZ, G. V. and GUEST, D., 1994, Aliphatic carboxylic acids. In Patty's Industrial Hygiene and Toxicology, 4th edn, vol. 2E, edited by G. D. Clayton and F. E. Clayton (New York: Wiley-Interscience), pp. 3553–3558.
  • KROGER, S., LlESIVUORI, J. and MANNINEN, A., 1990, Evaluation of workers' exposure to 2-ethylhexanoic acid (2-EHA) in Finnish sawmills: a field study. International Archives of Occupational and Environmental Health, 62, 213–216.
  • LUNDGREN, B., MEIJER, J. and DEPlERRE, J. W., 1987, Characterization of the induction of cytosolic and microsomal epoxide hydrolases by 2-ethylhexanoic acid in mouse liver. Drug Metabolism and Disposition, 15, 114–121.
  • METZLER, D. E., 1977. In Biochemistry: The Chemical Reactions of Living Cells (New York: Academic), 519 P.
  • MOODY, D. E. and REDDY, J. K., 1978, Hepatic peroxisome (microbody) proliferation in rat fed plasticizers and related compounds. Toxicology and Applied Pharmacology, 45, 497–504.
  • NAROTSKY, M. G., FRANCIS, E. Z. and KAVLOCK, R. J., 1994, Developmental toxicity and struc-ture—activity relationships of aliphatic acids, including dose—response assessment of valproic acid in mice and rats. Fundamental and Applied Toxicology, 22, 251–265.
  • PENNANEN, S. and MANNINEN, A., 1991, Distribution of 2-ethylhexanoic acid in mice and rat after an intraperitoneal injection. Pharmacology and Toxicology, 68, 57–59.
  • PENNANEN, S., AURIOLA, S., MANNINEN, A. and KOMULAINEN, H., 1991, Identification of the main metabolites of 2-ethylhexanoic acid in rat urine using gas chromatography-mass spectrometry. Journal of Chromatography-Biomedical Applications, 568, 125–134.
  • PENNANEN, S., TUOVINEN, K., HUUSKONEN, H. and KOMULAINEN, H., 1992, The developmental toxicity of 2-ethylhexanoic acid in Wistar rat. Fundamental and Applied Toxicology, 19, 505–511.
  • TAUBENECK, M. W., URIU-HARE, J. Y., COMMISSO, J. F., BORSCHERS, A. T., Bffi, L. M., FABER, W. and KEEN, C. L., 1996, Maternal exposure to 2-ethylhexanoic acid (EHXA), 2-ethylhexanol (EHXO), and valproic acid (VPA) results in alterations in maternal and embryonic zinc status. Teratology, 53(2), 88, Abstract 21.
  • UNITED STATES GENERAL ACCOUNTING OFFICE (October 1991). PEMD-92-3 (Washington: United States General Accounting Office).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.